Mica Duran

Daclizumab— Blockage of dendritic cell receptor 

Prev Next
Previous

Vedolizumab®

medical illustration of Part of a series; E-learning and booth graphics for therapeutic monoclonal antibody Daclizumab (Zenapax®) — Showing blockage of IL-2 receptor target. Drug's mechanism of action graphics at cellular level for pharmaceutical project. Keywords: molecular biology, cellular biology, histology, pharmacology, virology, disease management; multiple sclerosis
Next medical illustration of Graphic for healthcare professional education highlighting antibody interaction with systemic, mucosal and cellular immunity systems.

FluMist® Quadrivalent: Immunity Wheel

Part of a series; E-learning and booth graphics for therapeutic monoclonal antibody Daclizumab (Zenapax®) — Showing blockage of IL-2 receptor target. Drug's mechanism of action graphics at cellular level for pharmaceutical project. Keywords: molecular biology, cellular biology, histology, pharmacology, virology, disease management; multiple sclerosis

Keywords: Advertising / Marketing, Web, Allergy / Immunology, Cell biology / Histology, Disease Management, Genetics, Molecular Biology, Neuroscience, Pharmacology, Virology

© Mica Duran